authors
- Noth, I
- Wijsenbeek, M
- Kolb, Martin Rainer
- Bonella, F
- Moros, L
- Wachtlin, D
- Corte, TJ
Cardiovascular Safety Of Nintedanib In Subgroups By Cardiovascular Risk At Baseline In The Tomorrow And Inpulsis Trials
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 2017
has subject area
- 11 Medical and Health Sciences (FoR)
- Aged (MeSH)
- Atherosclerosis (MeSH)
- Cardiovascular Diseases (MeSH)
- Clinical Trials as Topic (MeSH)
- Disease Progression (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Idiopathic Pulmonary Fibrosis (MeSH)
- Incidence (MeSH)
- Indoles (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Myocardial Infarction (MeSH)
- Patient Safety (MeSH)
- Protein Kinase Inhibitors (MeSH)
- Respiratory System (Science Metrix)
- Risk Factors (MeSH)
- Treatment Outcome (MeSH)
- Vital Capacity (MeSH)
published in
- European Respiratory Journal Journal